This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 23, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 




 Genomics

Genetic sleuthing solves solve superbug outbreak that kills 6
The Associated Press via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In 2011, a deadly superbug spread through the nation's leading research hospital, killing six patients before it could be stopped. Scientists at the National Institutes of Health hospital in Bethesda, Md., scrubbed with bleach, locked down patients and even ripped out plumbing. In the end, it took gene detectives analyzing the germ's DNA to trace it to its source. More



Secrets to oldest living family's longevity: Genetics, quality of life
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers searching for clues to the elixir of long-life have studied the ancient island communities of the Ogliastra region for years now, and most conclude the secret lies in a mix of factors: genetic make-up, diet and environment and a sense of belonging to a community. More

Now Hiring! Disability Examination Providers

The VA Locum Tenens Program seeks physicians and psychologists to perform disability examinations for general medicine and mental health conditions. Physicians will provide compensation and pension examinations for Veterans who file for disability claims. This position requires extensive travel around the country. Compensation package includes salary and full travel. Send your CV to locumtenens@va.gov or contact us at 1-866-664-1030.


Study: Children of older men have more gene abnormalities
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Do older fathers doom their children to genetic disease? This is the question raised by a new study that says older men produce more gene mutations in the children they sire, boosting their risk of schizophrenia and autism and possibly other diseases. More

 Biotech/Diagnostics/Personalized Medicine


Sore throat treatment should be individually tailored
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Throat discomfort may have a variety of causes and a range of symptoms, all of which should be considered before decisions about treatment are made, report researchers. Most cases of sore throat can be managed with over-the-counter treatments and other remedies, according to the researchers. However, to date there is limited information available regarding consumers' perceptions of throat discomfort or their treatment needs. More

CARDIODX®

Your patient's blood doesn't tell you that they will get tired walking the dog. Or that they've had heartburn for the past 2 weeks. But it can tell you whether or not obstructive CAD is what's causing their symptoms. You may not need to go deeper than the blood to know what's happening. MORE


Personalized medicine — Medicine for the privileged?
Cancer Network (commentary)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At a time of intense scrutiny of the costs and benefits of medical treatments, "personalized medicine" holds its promise only at the substantial cost of widespread use of the awesome tools of molecular science. Can we really afford personalized medicine or, more specifically, are the benefits of personalized approaches to therapy worth the costs? More


Pharmaceutical products that make a difference
Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems and are always exploring new product opportunities. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Autism stem-cell therapy to be tested in children in trials
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Families with autistic children must navigate a condition where questions outnumber the answers, and therapies remain sparse and largely ineffective. A clinical trial being conducted by the Sutter Neuroscience Institute in Sacramento, Calif., to address this situation began recruiting participants today for a highly experimental stem cell therapy for autism. More

Blind mice given sight after device cracks retinal code
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Blind mice had their vision restored with a device that helped diseased retinas send signals to the brain, according to a study that may lead to new prosthetic technology for millions of sight-impaired people. Current devices are limited in the aid they provide to people with degenerative diseases of the retina, the part of the eye that converts light into electrical impulses to the brain. In research described in the Proceedings of the National Academy of Sciences, scientists cracked the code the retina uses to communicate with the brain. More

 Emerging Medical Technologies


'NanoJacket' shows potential for cancer treatment
FierceHealthIT    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Penn State College of Medicine are working on a new nanotechnology drug delivery system to treat breast cancer. The "NanoJacket" particle targets a gene mutation that causes overexpression of an oncogenic protein in breast cancer patients with poor outcomes and delivers an RNA segment that kills cancer cells. More

Researchers developing emergency treatment for internal bleeding
Medgadget    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers from Case Western University reported on progress towards a portable treatment for stopping internal bleeding. In the military, it is the leading cause of battlefield deaths. Yet, no effective portable treatment currently exists to stop internal bleeding, and even at a hospital, a treatment with a coagulation factor VIIa on a compassionate use basis puts the patient at risk of forming dangerous blood clots elsewhere in the body. More

 Managed Healthcare News


Health insurers see gains in serving poor and elderly
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Giant health insurers have been gobbling up smaller ones, partly to strike gold with a new government experiment allowing them to manage care for millions of the nation's sickest, poorest and oldest patients. More

Clinics go mobile to take healthcare to the street
NPR    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Mobile clinics have become common across the U.S. in the last two decades. The clinics aim to bring care to communities that are short on insurance and healthcare providers. But the clinics' focus on the uninsured has led some to question whether the mobile model will be rendered moot by expansions of insurance coverage under the Affordable Care Act. More

 FDA: New Treatments and Technology


FDA warns of dangerous dietary supplements
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration has received dozens of reports about harmful side effects — including stroke and death — linked to two dietary supplements currently on the market, Reumofan Plus and Reumofan Plus Premium. More

FDA extends review for Pfizer arthritis drug by 3 months
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration extended by three months its review of Pfizer's experimental rheumatoid arthritis treatment tofacitinib, one of the most promising new drugs in the company's pipeline. More

FAST FACTS
"Dietary supplements do not have to go through the same testing that drugs do, according to the National Center for Complementary and Alternative Medicine."
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Aug. 16, 2012
Aug. 9, 2012
Aug. 2, 2012
July 26, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063